Showing results (211-220 of 223) with videos related to
Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast CancerMiguel Martín, Angel L Guerrero-Zotano, María E Pérez-López, et al.Nature Cell Biology|April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.JCO Precision Oncology|April 10, 2025
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study AnalysisEric Hahnen, Jan Hauke, Karen Gelmon, et al.JTO Clinical and Research Reports|March 25, 2024
RET Fusion Testing in Patients With NSCLC: The RETING StudyEsther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2026
Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial CohortCarsten Denkert, Sivaramakrishna Rachakonda, Anika Pehl, et al.Cancer Cell|February 11, 2025
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtypingCarsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING StudyEsther Conde, Susana Hernandez, Rebeca Martinez, et al.NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.Pageof 23